Dr. Ali Ghamrawy serves as the esteemed Chairman of the Egyptian Drug Authority (EDA) since 2024, boasting a remarkable four-decade tenure in the pharmaceutical domain. With a wealth of experience spanning various sectors, including industrial and governmental roles, Dr. Ghamrawy has been instrumental in shaping regulatory policies and driving strategic initiatives.

His tenure as a former member of the Authority’s Board of Directors and investment advisor underscores his strategic vision and industry insight.

His consultancy work for pharmaceutical projects, coupled with executive leadership roles in multinational corporations across Egypt, Africa, and the Middle East from 1986 until 2015, highlight his comprehensive understanding of industry dynamics and regulatory complexities.

As Chairman of the EDA, Dr. Ghamrawy remains committed to advancing pharmaceutical excellence and fostering collaboration, promising to steer Egypt towards new heights of innovation and regulatory efficacy.